IL17A and myeloid sarcoma: For instance, IL-17 levels are elevated in patients with MS, and its inhibitors can mitigate brain damage, underscoring the role of IL-17 in promoting inflammation in the nervous system and exacerbating demyelination and axonal damage [73].